RegenxBio's IPO

RegenxBio raised a round of funding on September 17, 2015. Investors include Public.

RegenxBio is focused on the effort to translate the latest gene delivery research into therapeutic applications for diseases where there is serious unmet need. The company is developing novel therapeu…

Articles about RegenxBio's IPO: